Clinical Trials Directory

Trials / Completed

CompletedNCT03003000

Ibuprofen/Caffeine Lower Back or Neck Pain Study

A Randomized, Placebo- and Active-controlled Multi-country, Multi-centre Parallel Group Study to Evaluate the Efficacy and Safety of a Fixed Dose Combination of 400 mg Ibuprofen and 100 mg Caffeine Compared to Ibuprofen 400 mg and Placebo in Patients With Acute Lower Back or Neck Pain.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
635 (actual)
Sponsor
Boehringer Ingelheim · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To assess the efficacy and safety of a 400 mg ibuprofen/100 mg caffeine tablet in comparison to a 400 mg ibuprofen tablet for the treatment of acute lower back or neck pain. To assess the safety and tolerability of a 400 mg ibuprofen/100 mg caffeine tablet in comparison to a 400 mg ibuprofen tablet and a placebo tablet.

Conditions

Interventions

TypeNameDescription
DRUGibuprofen
DRUGcaffeine
DRUGplacebo

Timeline

Start date
2016-12-20
Primary completion
2017-09-24
Completion
2017-09-28
First posted
2016-12-26
Last updated
2019-06-07
Results posted
2019-06-07

Locations

18 sites across 2 countries: Germany, Russia

Source: ClinicalTrials.gov record NCT03003000. Inclusion in this directory is not an endorsement.